文献速递神经MR

定量磁敏感加权成像预测多发性硬化疾病活动性

Quantitative susceptibility-weighted imaging in predicting disease activity in multiple sclerosis.
PubMed 文献 · Neuroradiology · 2021-01-05

研究纳入多发性硬化患者,按有无强化病灶分为活动组与无活动组,用SWI相位值计算病灶铁含量。强化病灶的相位差值和铁含量显著低于非强化病灶(p<0.001),铁含量阈值2.8 μg/g的曲线下面积为0.909且敏感度良好。作者认为SWI相位值定量铁含量有希望作为区分活动与非活动病灶的生物标志物。

要点

  • 强化病灶的SWI相位差值和铁含量显著低于非强化病灶(p<0.001)。
  • 铁含量阈值2.8 μg/g区分强化与非强化病灶的AUC为0.909,敏感度良好。
  • SWI相位值定量铁含量有希望作为区分多发性硬化活动与非活动病灶的生物标志物。

核心结论

  • 用SWI相位值定量铁含量有希望作为区分多发性硬化活动与非活动病灶的生物标志物。

研究设计与样本

  • 研究为接受MRI的多发性硬化患者分组研究,按有无强化病灶分为活动病灶组(组1)和非活动病灶组(组2)。
  • 组1分析22例患者的69个强化病灶,组2分析29例患者的84个非强化病灶。
  • 使用SPIN软件通过绘制ROI计算病灶相位值(PL)和对侧正常白质相位值(PN),并计算相位差值(PS=PL−PN)和病灶铁含量(PS/3)。

关键影像表现/征象

  • 强化病灶的平均相位差值和经ROI体素校正的铁含量均显著低于非强化病灶(p<0.001)。

诊断标准与关键数值

  • 铁含量阈值2.8 μg/g区分强化与非强化病灶的曲线下面积为0.909,敏感度良好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Repeated use of Gadolinium (Gd) contrast for multiple sclerosis (MS) imaging leads to Gd deposition in brain. We aimed to study the utility of phase values by susceptibility weighted imaging (SWI) to assess the iron content in MS lesions to differentiate active and inactive lesions.

METHODS: MS persons who underwent MRI were grouped into group 1 with active lesions and group 2 with inactive lesions based on the presence or absence of contrast enhancing lesions. Phase values of lesions (PL) and contralateral normal white matter (PN) were calculated using the SPIN software by drawing ROI. Subtracted phase values (PS = PL - PN) and iron content (PS/3) of the lesions were calculated in both groups.

RESULTS: We analyzed 69 enhancing lesions from 22 patients (group 1) and 84 non-enhancing lesions from 29 patients (group 2). Mean-subtracted phase values and iron content corrected for voxels in ROI were significantly lower in enhancing lesions compared to non-enhancing lesions (p < 0.001). A cut-off value 2.8 μg/g for iron content showed area under the curve of 0.909 with good sensitivity.

CONCLUSION: Quantification of iron content using SWI phase values holds promise as a biomarker to differentiate active from inactive lesions of MS.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Vinayagamani S, Sabarish S, Nair SS, et al. Quantitative susceptibility-weighted imaging in predicting disease activity in multiple sclerosis. Neuroradiology. 2021. PMID: 33403447. doi:10.1007/s00234-020-02605-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。